Disclosure 0002083206-26-000007-1

SEC FORM 4

$20,202.53

Lexeo Therapeutics, Inc. (LXEO)

Sale of 4,117 shares at $4.9071 per share.

Reporting Person Tamayo Louis Edward · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002083206-26-000007 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Lexeo Therapeutics, Inc. (LXEO)." Disclosed 2026-08-19. https://desqlong.com/cards/0002083206-26-000007-1 (retrieved 2026-09-26).